These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12577726)

  • 21. Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting.
    Kandzari DE; Tuttle RH; Zidar JP; Jollis JG
    Am J Cardiol; 2006 May; 97(10):1467-72. PubMed ID: 16679085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac protection during acute myocardial infarction.
    Dubois C
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):19-21. PubMed ID: 19618593
    [No Abstract]   [Full Text] [Related]  

  • 23. Stents versus bypass grafting for left main coronary artery disease.
    Tayek JA
    N Engl J Med; 2008 Jul; 359(4):424; author reply 425. PubMed ID: 18655244
    [No Abstract]   [Full Text] [Related]  

  • 24. Lifestyle change after elective percutaneous transluminal coronary angioplasty: An Australian perspective.
    Astin F; Jones K
    J Clin Nurs; 2006 Dec; 15(12):1583-4. PubMed ID: 17118081
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stents versus bypass grafting for left main coronary artery disease.
    Arnold JR; Banning AP
    N Engl J Med; 2008 Jul; 359(4):424-5; author reply 425. PubMed ID: 18655246
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic value of early exercise testing after coronary stent implantation: a strategy of routine stress testing after percutaneous coronary intervention is not of proven benefit.
    Sedlis SP; Eisenberg MJ;
    Am J Cardiol; 2008 Jun; 101(11):1681. PubMed ID: 18489955
    [No Abstract]   [Full Text] [Related]  

  • 28. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).
    Lee TT; Feinberg L; Baim DS; Holmes DR; Aroesty JM; Carrozza JP; Cohen DJ; Ho KK; Cutlip DE
    Am J Cardiol; 2006 Sep; 98(6):718-21. PubMed ID: 16950169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCT Daily: new trials set to examine drug-eluting stents: doctors urged to weigh benefits, risks of drug-eluting stents on per patient basis.
    J Interv Cardiol; 2007 Feb; 20(1):33. PubMed ID: 17300397
    [No Abstract]   [Full Text] [Related]  

  • 31. Overview of systematic reviews on invasive treatment of stable coronary artery disease.
    Kuukasjärvi P; Malmivaara A; Halinen M; Hartikainen J; Keto PE; Talvensaari T; Tierala I; Mäkelä M
    Int J Technol Assess Health Care; 2006; 22(2):219-34. PubMed ID: 16571198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bare metal stents: no longer passé?
    Bavry AA; Bhatt DL
    J Invasive Cardiol; 2006 Sep; 18(9):403-4. PubMed ID: 16954576
    [No Abstract]   [Full Text] [Related]  

  • 33. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease?
    Klein LW
    J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stenting or coronary artery bypass surgery for triple vessel disease?].
    Sleilaty G; Achouh P; Fabiani JN
    Ann Cardiol Angeiol (Paris); 2009 Apr; 58(2):104-12. PubMed ID: 18930176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents vs. coronary-artery bypass grafting.
    Abbate A; Lipinski MJ
    N Engl J Med; 2008 Jun; 358(24):2642; author reply 2643-4. PubMed ID: 18557173
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents.
    Kuchulakanti PK; Torguson R; Chu WW; Canos DA; Rha SW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Mar; 97(6):792-7. PubMed ID: 16516578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percutaneous coronary interventions in patients with ischemic heart disease and chronic renal failure].
    Witkowski A
    Przegl Lek; 2005; 62 Suppl 2():55-6. PubMed ID: 16623121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary treatment of coronary bifurcations with DES: part I.
    Colombo A
    J Interv Cardiol; 2005 Oct; 18(5):351-4. PubMed ID: 16202109
    [No Abstract]   [Full Text] [Related]  

  • 40. Reducing psychosocial stress: a novel mechanism of improving survival from exercise training.
    Milani RV; Lavie CJ
    Am J Med; 2009 Oct; 122(10):931-8. PubMed ID: 19682669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.